Inventor
MCCARTHY JAMES R
US69 patents
⚠️ This page may combine multiple inventors who share the name “MCCARTHY JAMES R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROCRINE BIOSCIENCES INC
15 patentsUS5473104ADec 5, 1995
Process for the preparation of L-carnitine
NEUROCRINE BIOSCIENCES INC35 citations93
US6664261B2Dec 16, 2003
Pyrazolopyrimidines as CRF receptor antagonists
NEUROCRINE BIOSCIENCES INC28 citations92
US6211195B1Apr 3, 2001
CRF antagonistic thiophenopyridines
NEUROCRINE BIOSCIENCES INC25 citations92
US5959109ASep 28, 1999
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
NEUROCRINE BIOSCIENCES INC28 citations91
US6531475B1Mar 11, 2003
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC38 citations90
US6352990B1Mar 5, 2002
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC14 citations84
US6514982B1Feb 4, 2003
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC19 citations82
US6348466B1Feb 19, 2002
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC6 citations74
US7074797B2Jul 11, 2006
Pyrazolopyrimidines as CRF receptor antagonists
NEUROCRINE BIOSCIENCES INC6 citations73
US6469166B2Oct 22, 2002
Thiophenopyrimidines
NEUROCRINE BIOSCIENCES INC12 citations73
US6255310B1Jul 3, 2001
Thiophenopyrimidines
NEUROCRINE BIOSCIENCES INC11 citations73
US6288060B1Sep 11, 2001
Amino substituted pyrimidines and triazines
NEUROCRINE BIOSCIENCES INC8 citations72
US6133276AOct 17, 2000
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
NEUROCRINE BIOSCIENCES INC12 citations72
US6723721B2Apr 20, 2004
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC5 citations63
US6747034B2Jun 8, 2004
CRF receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC5 citations58
MERRELL DOW PHARMA
14 patentsUS5120764AJun 9, 1992
Inhibitors of lysyl oxidase
MERRELL DOW PHARMA167 citations98
US5378693AJan 3, 1995
2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositions
MERRELL DOW PHARMA27 citations92
US5064864ANov 12, 1991
Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
MERRELL DOW PHARMA12 citations73
US5011859AApr 30, 1991
Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
MERRELL DOW PHARMA14 citations73
US4997924AMar 5, 1991
5'-deoxy-4',5'-unsaturated-5'-substituted adenosines
MERRELL DOW PHARMA8 citations73
US4745222AMay 17, 1988
Novel aryloxycycloalkanolaminoalkylene aryl ketones
MERRELL DOW PHARMA5 citations71
US5147863ASep 15, 1992
2,2'-bi-1H-imidazoles
MERRELL DOW PHARMA3 citations63
US4996308AFeb 26, 1991
Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
MERRELL DOW PHARMA5 citations63
US5348964ASep 20, 1994
Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
MERRELL DOW PHARMA2 citations62
US5189052AFeb 23, 1993
Thione dopamine beta hydroxylase inhibitors
MERRELL DOW PHARMA2 citations62
US4810800AMar 7, 1989
Novel imidazole dopamine beta hydroxylase inhibitors
MERRELL DOW PHARMA5 citations62
US5112852AMay 12, 1992
Allenyl amines
MERRELL DOW PHARMA2 citations61
US4847288AJul 11, 1989
Allenyl amines
MERRELL DOW PHARMA2 citations61
US4743617AMay 10, 1988
Heterocyclyl-2-propyn-1-amines
MERRELL DOW PHARMA5 citations61
MERRELL PHARMA INC
8 patentsUS5977325ANov 2, 1999
2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
MERRELL PHARMA INC47 citations96
US5616702AApr 1, 1997
2-'-ethenylidene cytidine, uridine and guanosine derivatives
MERRELL PHARMA INC7 citations74
US5607925AMar 4, 1997
Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides
MERRELL PHARMA INC12 citations74
US5512678AApr 30, 1996
5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
MERRELL PHARMA INC9 citations73
US5589587ADec 31, 1996
Process for the preparation of ribonucleotide reductase inhibitors
MERRELL PHARMA INC8 citations71
US5760210AJun 2, 1998
Process for the preparation of ribonucleotide reductase inhibitors
MERRELL PHARMA INC5 citations70
US5830863ANov 3, 1998
Neurokinin A antagonists
MERRELL PHARMA INC7 citations69
US5521162AMay 28, 1996
Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine and methods of treating neoplastic and viral disease conditions
MERRELL PHARMA INC6 citations62
MCCARTHY JAMES R
7 patentsUS4540484ASep 10, 1985
Method and apparatus for separating selected particulate materials from a mixture of liquids and solids
MCCARTHY JAMES R10 citations74
US4308132ADec 29, 1981
Bituminous coal reagent and flotation process
MCCARTHY JAMES R9 citations74
US4222857ASep 16, 1980
Apparatus for separating selected particulate materials from a mixture of solids and liquids
MCCARTHY JAMES R14 citations74
US9206141B2Dec 8, 2015
Processes for preparing linezolid
MCCARTHY JAMES R3 citations63
US4452714AJun 5, 1984
Bituminous coal reagent and flotation process
MCCARTHY JAMES R6 citations63
US4372864AFeb 8, 1983
Reagent for froth flotation of bituminous coal
MCCARTHY JAMES R5 citations63
US4274949AJun 23, 1981
Froth separation apparatus
MCCARTHY JAMES R3 citations63
(unassigned)
3 patentsBRISTOL MYERS SQUIBB CO
1 patentDOW CHEMICAL CO
1 patentHOESCHST MARION ROUSSEL INC
1 patentShowing the top 50 of 69 patents by PatentIndex Score.